Skip to main content
OpenTrials

Clinical trial condition

Hepatosplenic T-cell Lymphoma

Explore clinical trials studying Hepatosplenic T-cell Lymphoma. Study availability and eligibility vary by location and protocol.

47 public trials 3 recruiting studies

Hepatosplenic T-cell Lymphoma trial results

Conditions
Aggressive NK Cell Leukemia, Cutaneous PTCL-NOS (CD8+ or CD56+ and Cytotoxic Marker), Cytotoxic PTCL-NOS (CD8+ or CD56+ and Cytotoxic Marker), +27 more
Locations
  • Dren Investigational Site Birmingham, Alabama, United States
  • Dren Investigational Site Duarte, California, United States
  • Dren Investigational Site Irvine, California, United States
  • Dren Investigational Site Redwood City, California, United States
View all 37 locations
Conditions
Adult T-Cell Leukemia/Lymphoma, Aggressive NK-cell Leukemia, Anaplastic Large Cell Lymphoma, ALK-Positive, +54 more
Locations
  • City of Hope Cancer Center (Data collection only) Duarte, California, United States
  • UNIVERSITY OF CALIFORNIA SAN DIEGO (Data collection only) San Diego, California, United States
  • University of California San Francisco (Data collection only) San Francisco, California, United States
  • Stanford University Medical Center (Data collection only) Stanford, California, United States
View all 26 locations
Conditions
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +32 more
Locations
  • City of Hope Duarte, California, United States
  • Yale University New Haven, Connecticut, United States
  • Northwestern University Chicago, Illinois, United States
  • Weill Cornell Medicine New York, United States
Conditions
Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin Lymphoma, +40 more
Locations
  • Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States
  • Abramson Cancer Center Philadelphia, Pennsylvania, United States
Conditions
Anaplastic Large Cell Lymphoma, ALK-Positive, Anaplastic Large Cell Lymphoma, ALK-negative, Enteropathy-Associated T-Cell Lymphoma, +21 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • University of Colorado Cancer Center, Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
Conditions
Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Hemic and Lymphatic Diseases, +15 more
Locations
  • Mayo Clinic, Arizona Scottsdale, Arizona, United States
  • Stanford University Stanford, California, United States
  • Emory University School Of Medicine Atlanta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States